Stay updated on ARO-APOC3 in Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.
Latest updates to the ARO-APOC3 in Dyslipidemia Clinical Trial page
- Check2 days agoChange DetectedAdded a broad list of trial locations across the United States, Australia, Canada, and New Zealand, and updated the study status to Completed. These changes reflect the open-label extension and expanded site participation.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.3.2 is displayed on the page, replacing v3.2.0.SummaryDifference0.0%
- Check38 days agoChange DetectedRemoved the government-funding notice warning that information may not be up to date, removing the explicit caveat about updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check52 days agoChange DetectedDifference0.3%
- Check81 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference4%
- Check88 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
Stay in the know with updates to ARO-APOC3 in Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Dyslipidemia Clinical Trial page.